Developer docs
API playgroundTry for free, no card

Search company profiles

Cliantha Research

Full company profile

uuid000cb1u

Namestring
Cliantha Research
Legal namestring
Cliantha Research
Websiteurl
cliantha.in
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Cliantha Research is a privately held, India-headquartered full-service Contract Research Organization (CRO) operating since approximately 2005 across clinical research, bioanalytical laboratory services, and biometric solutions. The company serves pharmaceutical, biotechnology, and consumer health companies, delivering projects from early-phase bioavailability/bioequivalence (BA-BE) and Phase I studies through late-phase patient-based clinical trials, alongside specialized consumer-product testing. Its therapeutic expertise spans Oncology, Dermatology, Respiratory, Vaccines, and Biosimilars.

The company's underlying technology stack combines physical infrastructure — state-of-the-art clinical sites and laboratories in India (Ahmedabad, Vadodara, Noida) and North America (St. Petersburg, Mississauga, Scarborough) — with specialized equipment including Environmental Exposure Chambers for allergy testing, Walk-In Humidity Chambers for anti-perspirant testing, and Hill Top Chambers for occlusive dermal delivery studies. Bioanalytical capabilities cover small molecule, large molecule (biologics/biosimilars), IVRT/IVPT, veterinary therapeutics, and clinical reference lab work. Biometric Solutions integrate biostatistics, programming, and data management, supported by an in-house eClinical platform for electronic trial management. Cumulative execution metrics include 8,500+ Early Phase studies, 275+ Late Phase trials, 5,500+ Consumer Clinical Research studies, 950+ validated bioanalytical methods, and 210+ successful global regulatory inspections.

Cliantha generates revenue through fee-for-service professional services contracts with enterprise clients, distributed via direct enterprise sales engagement ('Request a Proposal' channels) rather than self-service or transactional channels. The company has 1,500+ professionals and operates under founder/management ownership with no disclosed institutional investors or funding rounds. Recent visible strategic activity includes the 2014 acquisition of Karmic Lifesciences and a November 2025 Phase 2 trial completion in Toronto for Sen-Jam Pharmaceutical's SJP-001, positioning Cliantha within a multi-CRO sponsor ecosystem alongside TASK Clinical and KVK Tech. Leadership is led by CEO Vijay Patel, President Naveen Sharma, and Director Mukesh Raojibhai Patel.

Short descriptiontext

Cliantha Research is a privately held India-headquartered full-service Contract Research Organization delivering early- and late-phase clinical trials, bioanalytical lab services, and biometric solutions to pharmaceutical, biotech, and consumer health companies across India, the USA, and Canada.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersAhmedabad, India
HQ citystring
Ahmedabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, contract research organization, bioequivalence studies, bioanalytical laboratory, clinical trial management
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code4 codes
  • Medical Laboratories621511
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Research Services
TypeProfessional Services
Description

Contract research organization providing fee-for-service clinical research across all phases from early phase BA-BE/Phase I through late phase patient-based trials. Revenue is generated through project-based contracts with pharmaceutical, biotech, and consumer health companies.

cliantha.com
2Laboratory Services
TypeProfessional Services
Description

Bioanalytical testing services for small molecules, large molecules, IVRT/IVPT, and clinical reference lab services billed per assay or study.

cliantha.com
3Consumer Clinical Research
TypeProfessional Services
Description

Specialized clinical testing for consumer products including allergy testing, anti-perspirant testing, and other consumer health product studies.

cliantha.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cliantha Research is a globally accredited full-service Contract Research Organization (CRO) providing integrated clinical research services across all phases of drug development. Its core offerings span early-phase BA-BE and Phase I studies, late-phase patient-based clinical trials, bioanalytical laboratory services for small and large molecules, and biometric/data management solutions, supported by specialized dermatology and inhalation infrastructure.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Cliantha Research is a globally accredited full-service Contract Research Organization (CRO) offering integrated clinical research services across all phases of drug development. The company operates a unified platform combining clinical trial services (Early Phase BA-BE/Phase I, Late Phase patient-based trials, Consumer Clinical Research), comprehensive bioanalytical lab services (Small Molecule, Large Molecule, IVRT/IVPT, Veterinary Therapeutics, Clinical Reference Lab), and biometric solutions (Biostatistics & Programming, Data Management). The portfolio spans therapeutic expertise in Oncology, Dermatology, Respiratory, Biosimilars, and Vaccines, supported by specialized capabilities including Environmental Exposure Chambers for allergy testing, Walk-In Humidity Chambers for anti-perspirant testing, and Hill Top Chambers for occlusive dermal delivery studies. The company also provides eClinical solutions for electronic trial management. Cliantha Research maintains clinical sites and laboratories in India (Ahmedabad, Vadodara, Noida) and North America (St. Petersburg USA; Mississauga, Scarborough Canada).

Product and service5 records
1Early-Phase (BA-BE / Phase I) Clinical Studies
CategoryEarly-Phase Clinical Research
Description

Full-service early-phase clinical research including bioequivalence (BA-BE) and Phase I studies, conducted for pharmaceutical and biotech sponsors requiring FDA-, EMA-, ANVISA-, WHO-, and DCGI-compliant execution for generic and new drug development programs.

2Late-Phase Patient-Based Clinical Trials
CategoryLate-Phase Clinical Research
Description

Late-phase, patient-based clinical trial management across multiple therapeutic areas for global pharmaceutical and biotech sponsors, with operations across India, North America, and Europe.

3Bioanalytical Laboratory Services
CategoryBioanalytical Laboratory Services
Description

In-house bioanalytical laboratory services providing validated analytical method development and sample analysis for small molecules and large molecules (biologics/biosimilars) to support clinical and bioequivalence programs for pharmaceutical and biotech sponsors.

4Biometric and Data Management Services
CategoryBiometrics and Data Management
Description

Biometrics, data management, and biostatistics services supporting clinical trial design, database build, statistical analysis, and regulatory submission deliverables for clinical research sponsors.

5Dermatology and Inhalation Clinical Studies
CategorySpecialty Clinical Research
Description

Specialized clinical study services for dermatology, cosmetic/topical, and inhalation products, enabled by environmental exposure chambers, humidity-controlled chambers, and in-vitro release/permeation testing (IVRT/IVPT), targeting consumer health, personal care, and pharmaceutical sponsors.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1TASK Clinical
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-11
Description

TASK Clinical, a global contract research organization, partnered with Sen-Jam Pharmaceutical for the Phase 3 trial of SJP-001. Cliantha Research conducted the Phase 2 trial for this therapeutic in Toronto, completed in November 2025, with data readout expected in Q1 2026. TASK Clinical is funding two-thirds of the Phase 3 trial in exchange for equity.

prnewswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

KVK Tech serves as corporate venture partner to Sen-Jam Pharmaceutical, handling formulation, CMC, and FDA submission readiness. This partnership represents a vertically integrated development ecosystem. Cliantha Research conducted Phase 2 trials as part of this ecosystem.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global CRO offering clinical trial management, bioanalytical services, and regulatory consulting. Comparable full-service platform with stronger late-phase and global regulatory depth than Cliantha.

TypeBroad incumbent
Description

India-headquartered CDMO/CRO with clinical development and bioanalytical capabilities. Comparable integrated India-based platform with broader contract manufacturing scale than Cliantha.

TypeDirect peer
Description

Global full-service biopharmaceutical solutions organization spanning clinical development and commercial services. Competes head-to-head with Cliantha for clinical trial outsourcing across all phases and therapeutic areas.

4Syngene International
TypeDirect peer
Description

Leading India-based CRO/CDMO offering discovery, development, and clinical research services with bioanalytical labs. Comparable integrated India-anchored CRO platform, listed on Indian exchanges with much larger disclosed scale.

TypeDirect peer
Description

Top-tier global full-service CRO formed via the PRA Health Sciences merger, offering Phase I-IV clinical services, bioanalytical labs, and biometrics. Comparable integrated CRO model serving pharma/biotech across all phases, with much larger global footprint.

TypeRegional player
Description

India-based CRO offering BA-BE/Phase I, Phase II-IV, bioanalytical, and clinical trial services. Comparable mid-tier Indian CRO competing for similar sponsors and geographies.

7Veeda Clinical Research
TypeRegional player
Description

India-based full-service CRO offering BA-BE/Phase I, bioanalytical, and clinical research services. Closest like-for-like Indian mid-tier competitor to Cliantha with similar Early Phase and bioanalytical focus.

TypeDirect peer
Description

Major CRO with strong bioanalytical, preclinical, and clinical services portfolios. Comparable bioanalytical lab capabilities and Early Phase (BA-BE/Phase I) focus, with greater scale and US-centric footprint.

9Labcorp / Fortrea (Covance spin-off)
TypeDirect peer
Description

Fortrea (spun from Labcorp/Covance) is a global CRO providing Phase I-IV clinical services and central lab/bioanalytical capabilities. Directly comparable full-service model targeting pharma/biotech sponsors globally.

TypeBroad incumbent
Description

Largest global full-service CRO with end-to-end clinical, bioanalytical, and real-world evidence capabilities. Directly competes with Cliantha for multi-phase, multi-region pharma/biotech contracts, but at vastly greater scale and preferred-provider relationships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cliantha Research

Contract Research Organization (CRO) Servicescliantha.in

Cliantha Research is a privately held India-headquartered full-service Contract Research Organization delivering early- and late-phase clinical trials, bioanalytical lab services, and biometric solutions to pharmaceutical, biotech, and consumer health companies across India, the USA, and Canada.

What Cliantha Research does

Cliantha Research is a privately held, India-headquartered full-service Contract Research Organization (CRO) operating since approximately 2005 across clinical research, bioanalytical laboratory services, and biometric solutions. The company serves pharmaceutical, biotechnology, and consumer health companies, delivering projects from early-phase bioavailability/bioequivalence (BA-BE) and Phase I studies through late-phase patient-based clinical trials, alongside specialized consumer-product testing. Its therapeutic expertise spans Oncology, Dermatology, Respiratory, Vaccines, and Biosimilars.

The company's underlying technology stack combines physical infrastructure — state-of-the-art clinical sites and laboratories in India (Ahmedabad, Vadodara, Noida) and North America (St. Petersburg, Mississauga, Scarborough) — with specialized equipment including Environmental Exposure Chambers for allergy testing, Walk-In Humidity Chambers for anti-perspirant testing, and Hill Top Chambers for occlusive dermal delivery studies. Bioanalytical capabilities cover small molecule, large molecule (biologics/biosimilars), IVRT/IVPT, veterinary therapeutics, and clinical reference lab work. Biometric Solutions integrate biostatistics, programming, and data management, supported by an in-house eClinical platform for electronic trial management. Cumulative execution metrics include 8,500+ Early Phase studies, 275+ Late Phase trials, 5,500+ Consumer Clinical Research studies, 950+ validated bioanalytical methods, and 210+ successful global regulatory inspections.

Cliantha generates revenue through fee-for-service professional services contracts with enterprise clients, distributed via direct enterprise sales engagement ('Request a Proposal' channels) rather than self-service or transactional channels. The company has 1,500+ professionals and operates under founder/management ownership with no disclosed institutional investors or funding rounds. Recent visible strategic activity includes the 2014 acquisition of Karmic Lifesciences and a November 2025 Phase 2 trial completion in Toronto for Sen-Jam Pharmaceutical's SJP-001, positioning Cliantha within a multi-CRO sponsor ecosystem alongside TASK Clinical and KVK Tech. Leadership is led by CEO Vijay Patel, President Naveen Sharma, and Director Mukesh Raojibhai Patel.

Cliantha Research firmographics

Firmographics
Name
Cliantha Research
Legal name
Cliantha Research
Website
https://cliantha.in
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Cliantha Research is a privately held India-headquartered full-service Contract Research Organization delivering early- and late-phase clinical trials, bioanalytical lab services, and biometric solutions to pharmaceutical, biotech, and consumer health companies across India, the USA, and Canada.
Ownership category
akta.pro rank

Cliantha Research industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Medical Laboratories (621511), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical research services
  • Contract research organization
  • Bioequivalence studies
  • Bioanalytical laboratory
  • Clinical trial management

Where Cliantha Research is headquartered

Location

Headquarters

HQ city
Ahmedabad
HQ country
India
HQ region
Asia

Offices6 records

Markets served

Cliantha Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Research Services: Contract research organization providing fee-for-service clinical research across all phases from early phase BA-BE/Phase I through late phase patient-based trials. Revenue is generated through project-based contracts with pharmaceutical, biotech, and consumer health companies.
  2. Laboratory Services: Bioanalytical testing services for small molecules, large molecules, IVRT/IVPT, and clinical reference lab services billed per assay or study.
  3. Consumer Clinical Research: Specialized clinical testing for consumer products including allergy testing, anti-perspirant testing, and other consumer health product studies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Cliantha Research product offering

Product offering

Core offering

Cliantha Research is a globally accredited full-service Contract Research Organization (CRO) providing integrated clinical research services across all phases of drug development. Its core offerings span early-phase BA-BE and Phase I studies, late-phase patient-based clinical trials, bioanalytical laboratory services for small and large molecules, and biometric/data management solutions, supported by specialized dermatology and inhalation infrastructure.

Product overview

Cliantha Research is a globally accredited full-service Contract Research Organization (CRO) offering integrated clinical research services across all phases of drug development. The company operates a unified platform combining clinical trial services (Early Phase BA-BE/Phase I, Late Phase patient-based trials, Consumer Clinical Research), comprehensive bioanalytical lab services (Small Molecule, Large Molecule, IVRT/IVPT, Veterinary Therapeutics, Clinical Reference Lab), and biometric solutions (Biostatistics & Programming, Data Management). The portfolio spans therapeutic expertise in Oncology, Dermatology, Respiratory, Biosimilars, and Vaccines, supported by specialized capabilities including Environmental Exposure Chambers for allergy testing, Walk-In Humidity Chambers for anti-perspirant testing, and Hill Top Chambers for occlusive dermal delivery studies. The company also provides eClinical solutions for electronic trial management. Cliantha Research maintains clinical sites and laboratories in India (Ahmedabad, Vadodara, Noida) and North America (St. Petersburg USA; Mississauga, Scarborough Canada).

Differentiator

Problem solved

Functional benefit

Products and services

  • Early-Phase (BA-BE / Phase I) Clinical Studies Full-service early-phase clinical research including bioequivalence (BA-BE) and Phase I studies, conducted for pharmaceutical and biotech sponsors requiring FDA-, EMA-, ANVISA-, WHO-, and DCGI-compliant execution for generic and new drug development programs.
  • Late-Phase Patient-Based Clinical Trials Late-phase, patient-based clinical trial management across multiple therapeutic areas for global pharmaceutical and biotech sponsors, with operations across India, North America, and Europe.
  • Bioanalytical Laboratory Services In-house bioanalytical laboratory services providing validated analytical method development and sample analysis for small molecules and large molecules (biologics/biosimilars) to support clinical and bioequivalence programs for pharmaceutical and biotech sponsors.
  • Biometric and Data Management Services Biometrics, data management, and biostatistics services supporting clinical trial design, database build, statistical analysis, and regulatory submission deliverables for clinical research sponsors.
  • Dermatology and Inhalation Clinical Studies Specialized clinical study services for dermatology, cosmetic/topical, and inhalation products, enabled by environmental exposure chambers, humidity-controlled chambers, and in-vitro release/permeation testing (IVRT/IVPT), targeting consumer health, personal care, and pharmaceutical sponsors.

Companies that use Cliantha Research

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Cliantha Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Cliantha Research partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • TASK ClinicalcoreStrategic or Co-development Partner · 11 December 2025TASK Clinical, a global contract research organization, partnered with Sen-Jam Pharmaceutical for the Phase 3 trial of SJP-001. Cliantha Research conducted the Phase 2 trial for this therapeutic in Toronto, completed in November 2025, with data readout expected in Q1 2026. TASK Clinical is funding two-thirds of the Phase 3 trial in exchange for equity.
  • KVK TechcoreStrategic or Co-development PartnerKVK Tech serves as corporate venture partner to Sen-Jam Pharmaceutical, handling formulation, CMC, and FDA submission readiness. This partnership represents a vertically integrated development ecosystem. Cliantha Research conducted Phase 2 trials as part of this ecosystem.

Scale indicators9 records

Recent moves5 records

Expansion highlights5 records

Cliantha Research competitors and assessment

Company assessment

Direct peers

  • Parexel International: Global CRO offering clinical trial management, bioanalytical services, and regulatory consulting. Comparable full-service platform with stronger late-phase and global regulatory depth than Cliantha.
  • Syneos Health: Global full-service biopharmaceutical solutions organization spanning clinical development and commercial services. Competes head-to-head with Cliantha for clinical trial outsourcing across all phases and therapeutic areas.
  • Syngene International: Leading India-based CRO/CDMO offering discovery, development, and clinical research services with bioanalytical labs. Comparable integrated India-anchored CRO platform, listed on Indian exchanges with much larger disclosed scale.
  • ICON plc: Top-tier global full-service CRO formed via the PRA Health Sciences merger, offering Phase I-IV clinical services, bioanalytical labs, and biometrics. Comparable integrated CRO model serving pharma/biotech across all phases, with much larger global footprint.
  • Charles River Laboratories: Major CRO with strong bioanalytical, preclinical, and clinical services portfolios. Comparable bioanalytical lab capabilities and Early Phase (BA-BE/Phase I) focus, with greater scale and US-centric footprint.
  • Labcorp / Fortrea (Covance spin-off): Fortrea (spun from Labcorp/Covance) is a global CRO providing Phase I-IV clinical services and central lab/bioanalytical capabilities. Directly comparable full-service model targeting pharma/biotech sponsors globally.

Broad incumbents

  • Piramal Pharma Solutions: India-headquartered CDMO/CRO with clinical development and bioanalytical capabilities. Comparable integrated India-based platform with broader contract manufacturing scale than Cliantha.
  • IQVIA: Largest global full-service CRO with end-to-end clinical, bioanalytical, and real-world evidence capabilities. Directly competes with Cliantha for multi-phase, multi-region pharma/biotech contracts, but at vastly greater scale and preferred-provider relationships.

Regional players

  • Lambda Therapeutic Research: India-based CRO offering BA-BE/Phase I, Phase II-IV, bioanalytical, and clinical trial services. Comparable mid-tier Indian CRO competing for similar sponsors and geographies.
  • Veeda Clinical Research: India-based full-service CRO offering BA-BE/Phase I, bioanalytical, and clinical research services. Closest like-for-like Indian mid-tier competitor to Cliantha with similar Early Phase and bioanalytical focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cliantha Research social profiles

Digital presence

Cliantha Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cliantha Research leadership team

Management profile

Number of profiles

Profiles3 records

Cliantha Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cliantha Research M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cliantha Research

What does Cliantha Research do?

Cliantha Research is a globally accredited full-service Contract Research Organization (CRO) providing integrated clinical research services across all phases of drug development. Its core offerings span early-phase BA-BE and Phase I studies, late-phase patient-based clinical trials, bioanalytical laboratory services for small and large molecules, and biometric/data management solutions, supported by specialized dermatology and inhalation infrastructure.

Is Cliantha Research a public or private company?

Cliantha Research is a private company. It is classified as corporate owned and is currently operating.

When was Cliantha Research founded?

Cliantha Research was founded in 2005. It employs 1,001 to 5,000 people.

Where is Cliantha Research based?

Cliantha Research is headquartered in Ahmedabad, India, in the Asia region.

How does Cliantha Research make money?

Three revenue lines are on record. Clinical Research Services are the primary driver. The others are laboratory Services and consumer Clinical Research.

Who are Cliantha Research's main competitors?

Direct peers on record are Parexel International, Syneos Health, Syngene International, ICON plc, Charles River Laboratories and Labcorp / Fortrea (Covance spin-off). Broad incumbents are Piramal Pharma Solutions and IQVIA. Regional players are Lambda Therapeutic Research and Veeda Clinical Research.

Does Cliantha Research have an API?

No public API is recorded for Cliantha Research.

What industry is Cliantha Research in?

Cliantha Research's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals